SCHEMBL17300613

SCHEMBL17300613

Cc1ccc2c(c1O)C(=O)N(C(C)C)C2=O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ELANE P08246 5/20 0.49
CTSG P08311 1/20 0.41
USP2 O75604 1/20 0.39
KDM4E B2RXH2 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TDP2 O95551 1/20 0.37
NSD2 O96028 1/20 0.37
HSP90AA1 P07900 1/20 0.37
PAX8 Q06710 1/20 0.37
ALDH1A1 P00352 3/20 0.34
NPC1 O15118 1/20 0.34
CYP3A4 P08684 1/20 0.34
TSHR P16473 1/20 0.34
MAPK1 P28482 1/20 0.34
CASP3 P42574 1/20 0.34
RAB9A P51151 1/20 0.34
HBB P68871 1/20 0.34
SMN1; SMN2 Q16637 1/20 0.34
SENP7 Q9BQF6 1/20 0.34
SENP6 Q9GZR1 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19425897 0.84 KDM4E (0.44) ELANEUSP2KDM4EHSD17B10ALDH1A1
SCHEMBL24303347 0.82 TDP2 (0.48) ELANEUSP2KDM4EHSD17B10TDP2
SCHEMBL17300619 0.76 ELANE (0.45) ELANECTSGKDM4EHSD17B10TDP2
SCHEMBL12420865 0.75 DPP4 (0.47) USP2ALDH1A1
SCHEMBL17300617 0.72 GPR119 (0.38) USP2KDM4EALDH1A1TSHRGPR119
SCHEMBL17300612 0.72 GPR119 (0.35) USP2GPR119
SCHEMBL17300614 0.71 KDM4E (0.38) ELANEUSP2KDM4EALDH1A1GPR119
SCHEMBL17300618 0.71 KDM4E (0.38) ELANEUSP2KDM4EALDH1A1HPGD
SCHEMBL11019005 0.71 DPP4 (0.68) ELANECTSGCYP3A4TSHRLMNA
SCHEMBL12381797 0.71 NPC1 (0.42) USP2KDM4EALDH1A1NPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150344502-A1 CEPHEM COMPOUND SHIONOGI & CO., LTD. (JP) 2015-12-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150344502-A1 CEPHEM COMPOUND PRMT6, CEP170, NR0B1 ELANE 3167/4885CTSG 4284/4885USP2 1669/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.